Tidjane Thiam’s Freedom Acquisition Corporation is in talks to merge with the life sciences group for an implied valuation of close to US$1 billion.
Tidjane is featured in this article by the Financial Times regarding the announcement that his special purpose acquisition company (SPAC) has discovered a better fit in Chinese businessman Edward Zeng than Pimco, the US investment giant.